Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Molecular Genetics and Metabolism|September 28, 2011
Pathogenesis of aortic dilatation in mucopolysaccharidosis VII mice may involve complement activationGuilherme Baldo, Susan Wu, Ruth A Howe, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 16, 2006
Mucopolysaccharidosis I cats mount a cytotoxic T lymphocyte response after neonatal gene therapy that can be blocked with CTLA4-IgKatherine P Ponder, Baomei Wang, Ping Wang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 24, 2007
Correction of clinical manifestations of canine mucopolysaccharidosis I with neonatal retroviral vector gene therapyAnne M Traas, Ping Wang, Xiucui Ma, et al.
Molecular Genetics and Metabolism|July 17, 2013
Pathogenesis of mitral valve disease in mucopolysaccharidosis VII dogsPaul W Bigg, Guilherme Baldo, Meg M Sleeper, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 8, 2012
Neonatal gene therapy with a gamma retroviral vector in mucopolysaccharidosis VI catsKatherine P Ponder, Thomas M O'Malley, Ping Wang, et al.
Molecular Genetics and Metabolism|July 27, 2010
Early versus late treatment of spinal cord compression with long-term intrathecal enzyme replacement therapy in canine mucopolysaccharidosis type IPatricia I Dickson, Stephen Hanson, Michael F McEntee, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 9, 2015
Evaluation of AAV-mediated Gene Therapy for Central Nervous System Disease in Canine Mucopolysaccharidosis VIIBrittney L Gurda, Adrien De Guilhem De Lataillade, Peter Bell, et al.
Pageof 4